Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$3.91 - $5.93 $821 - $1,245
210 Added 39.03%
748 $4,000
Q3 2023

Nov 14, 2023

SELL
$4.6 - $7.95 $32,176 - $55,610
-6,995 Reduced 92.86%
538 $2,000
Q2 2023

Aug 14, 2023

SELL
$5.66 - $7.59 $23,183 - $31,088
-4,096 Reduced 35.22%
7,533 $48,000
Q1 2023

May 15, 2023

BUY
$7.31 - $11.18 $85,007 - $130,012
11,629 New
11,629 $87,000
Q3 2022

Nov 14, 2022

BUY
$9.2 - $13.68 $336,030 - $499,662
36,525 New
36,525 $361,000

Others Institutions Holding ABCL

About AbCellera Biologics Inc.


  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $841M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.